Cargando…
Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase
Metformin is considered to be one of the most effective therapeutics for the treatment of type 2 diabetes (T2D) since it specifically reduces hepatic gluconeogenesis without increasing insulin secretion, inducing weight gain, or posing a risk of hypoglycemia(1,2). For over half a century, this agent...
Autores principales: | Madiraju, Anila K., Erion, Derek M., Rahimi, Yasmeen, Zhang, Xian-Man, Braddock, Demetrios, Albright, Ronald A., Prigaro, Brett J., Wood, John L., Bhanot, Sanjay, MacDonald, Michael J., Jurczak, Michael, Camporez, Joao-Paulo, Lee, Hui-Young, Cline, Gary W., Samuel, Varman T., Kibbey, Richard G., Shulman, Gerald I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4074244/ https://www.ncbi.nlm.nih.gov/pubmed/24847880 http://dx.doi.org/10.1038/nature13270 |
Ejemplares similares
-
Metformin Inhibits Gluconeogenesis by a Redox-Dependent Mechanism In Vivo
por: Madiraju, Anila K., et al.
Publicado: (2018) -
LACTIC AND α-GLYCEROPHOSPHATE DEHYDROGENASES IN INSECTS
por: Zebe, E. C., et al.
Publicado: (1957) -
Targeting Pyruvate Carboxylase Reduces Gluconeogenesis and Adiposity and Improves Insulin Resistance
por: Kumashiro, Naoki, et al.
Publicado: (2013) -
ApoA5 knockdown improves whole-body insulin sensitivity in high-fat-fed mice by reducing ectopic lipid content
por: Camporez, João Paulo G., et al.
Publicado: (2015) -
Metformin, phenformin, and galegine inhibit complex IV activity and reduce glycerol-derived gluconeogenesis
por: LaMoia, Traci E., et al.
Publicado: (2022)